2026 Q2 Portfolio Activity
In 2026 Q2, Rosalind Advisors, Inc. maintained a portfolio of 45 distinct positions. The most significant new addition was ABIVAX SA, now representing 1.03% of the total fund value. They heavily accumulated shares in FENNEC PHARMACEUTICALS INC, increasing the position by 9.6%. Conversely, Rosalind Advisors, Inc. completely exited their position in CG ONCOLOGY INC.
Position History
hover any row below to update
Loading…
Total Positions
45
Quarter
2026 Q2
Top Holding
DCTH (15.4%)
Top 10 Concentration
74.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-45 of 45
Rosalind Advisors, Inc. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DCTH
DELCATH SYSTEMS...
|
Healthcare | 15.44% | 12.31% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
3,300,389 | $41,551,898 |
$8.01
+114.0%
|
2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
FENC
FENNEC PHARMACE...
|
Healthcare | 12.73% | 7.19% |
#2
1
Prev: #3
|
7.5 |
—
|
279,800 | 9.6% |
P
S
|
3,188,001 | $34,271,011 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 8.56% | 7.53% |
#3
1
Prev: #2
|
4.9 |
—
|
-322,719 | -10.0% |
P
S
|
2,908,981 | $23,039,130 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 7.27% | 7.03% |
#4
Prev: #4
|
3.9 |
—
|
-25,600 | -0.8% |
P
S
|
3,178,121 | $19,577,225 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 5.66% | 4.55% |
#5
5
Prev: #10
|
5.8 |
—
|
1,848,034 | 86.4% |
P
S
|
3,986,509 | $15,228,464 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 5.58% | 5.33% |
#6
1
Prev: #7
|
3.2 |
—
|
no change | no change |
P
S
|
3,214,766 | $15,012,957 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EYPT
EYEPOINT PHARMA...
|
Healthcare | 5.25% | 5.37% |
#7
1
Prev: #6
|
2.6 |
—
|
-48,507 | -4.7% |
P
S
|
988,230 | $14,131,689 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYBN
CYBIN INC
|
Unknown | 4.80% | 2.95% |
#8
5
Prev: #13
|
4.4 |
—
|
425,000 | 27.7% |
P
S
|
1,956,814 | $12,934,541 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 4.44% | 5.02% |
#9
1
Prev: #8
|
2.3 |
—
|
-51,400 | -7.3% |
P
S
|
648,600 | $11,940,726 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 4.32% | 6.77% |
#10
5
Prev: #5
|
1.7 |
—
|
-90,000 | -31.0% |
P
S
|
200,000 | $11,626,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDWD
MEDIWOUND LTD
|
Healthcare | 4.09% | 4.85% |
#11
2
Prev: #9
|
2.6 |
—
|
no change | no change |
P
S
|
749,054 | $11,011,094 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 2.76% | 4.21% |
#12
1
Prev: #11
|
1.1 |
—
|
-130,000 | -39.4% |
P
S
|
200,000 | $7,442,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 2.68% | 3.53% |
#13
1
Prev: #12
|
1.1 |
—
|
-201,553 | -21.8% |
P
S
|
721,504 | $7,215,040 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PROF
PROFOUND MEDICA...
|
Healthcare | 2.05% | 2.16% |
#14
3
Prev: #17
|
1.8 |
—
|
no change | no change |
P
S
|
828,118 | $5,506,985 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TLPH
TALPHERA INC
|
Healthcare | 1.98% | 1.01% |
#15
7
Prev: #22
|
3.8 |
—
|
1,815,585 | 54.1% |
P
S
|
5,169,501 | $5,324,586 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVIR
ATEA PHARMACEUT...
|
Healthcare | 1.85% | 2.53% |
#16
Prev: #16
|
1.2 |
—
|
-101,305 | -8.6% |
P
S
|
1,070,550 | $4,978,058 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MYO
MYOMO INC
|
Healthcare | 1.41% | 1.04% |
#17
4
Prev: #21
|
1.1 |
—
|
-209,386 | -5.4% |
P
S
|
3,637,886 | $3,783,401 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 1.11% | 0.99% |
#18
5
Prev: #23
|
1.4 |
—
|
no change | no change |
P
S
|
1,107,994 | $2,980,504 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NRXS
NEURAXIS INC
|
Healthcare | 1.10% | 0.68% |
#19
8
Prev: #27
|
3.4 |
—
|
221,917 | 77.6% |
P
S
|
508,055 | $2,971,106 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.03% | — |
#20
Prev: #—
|
3.9 |
—
|
20,869 | — |
NEW
|
20,869 | $2,781,003 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NSPR
INSPIREMD INC
|
Healthcare | 1.02% | 2.56% |
#21
6
Prev: #15
|
1.4 |
—
|
no change | no change |
P
S
|
3,905,743 | $2,734,411 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
REGENTIS BIOMAT...
|
|
Unknown | 0.92% | 0.31% |
#22
13
Prev: #35
|
3.4 |
—
|
450,175 | 179.0% |
P
S
|
701,685 | $2,476,948 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
SELLAS LIFE SCI...
|
|
PUT Option | 0.86% | — |
#23
Prev: #—
|
3.8 |
—
|
568,700 | — |
NEW
|
568,700 | $2,302,500 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PYPD
POLYPID LTD
|
Healthcare | 0.73% | 1.05% |
#24
4
Prev: #20
|
0.3 |
—
|
-208,471 | -34.9% |
P
S
|
389,455 | $1,978,431 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BFRI
BIOFRONTERA INC
|
Healthcare | 0.45% | 0.38% |
#25
8
Prev: #33
|
2.2 |
—
|
111,647 | 9.6% |
P
S
|
1,275,609 | $1,206,088 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.41% | 0.33% |
#26
8
Prev: #34
|
1.2 |
—
|
no change | no change |
P
S
|
100,000 | $1,097,000 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.40% | — |
#27
Prev: #—
|
3.7 |
—
|
20,000 | — |
NEW
|
20,000 | $1,080,000 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 0.39% | 0.42% |
#28
3
Prev: #31
|
1.2 |
—
|
no change | no change |
P
S
|
250,000 | $1,040,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 0.25% | 0.74% |
#29
4
Prev: #25
|
0.1 |
—
|
-293,763 | -66.2% |
P
S
|
150,000 | $684,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PEPG
PEPGEN INC
|
Healthcare | 0.23% | — |
#30
Prev: #—
|
3.6 |
—
|
350,000 | — |
NEW
|
350,000 | $630,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CALL
CG ONCOLOGY INC
|
|
CALL Option | 0.14% | — |
#31
Prev: #—
|
3.6 |
—
|
31,000 | — |
NEW
|
31,000 | $375,100 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
CALL
EYEPOINT PHARMA...
|
|
CALL Option | 0.05% | — |
#32
Prev: #—
|
3.5 |
—
|
50,300 | — |
NEW
|
50,300 | $130,780 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
ISHARES TR
|
|
PUT Option | 0.04% | — |
#33
Prev: #—
|
3.5 |
—
|
500,000 | — |
NEW
|
500,000 | $110,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
SPDR SERIES TRU...
|
|
PUT Option | 0.01% | — |
#34
Prev: #—
|
3.5 |
—
|
140,600 | — |
NEW
|
140,600 | $35,150 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
TENAX THERAPEUT...
|
|
PUT Option | 0.01% | — |
#35
Prev: #—
|
3.5 |
—
|
6,200 | — |
NEW
|
6,200 | $13,950 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
VIRIDIAN THERAP...
|
|
PUT Option | 0.00% | 0.02% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-263,600 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
SPDR S&P 500 ET...
|
|
PUT Option | 0.00% | 0.39% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-125,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
PUT
INVESCO QQQ TR
|
|
PUT Option | 0.00% | 0.42% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-250,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ANNX
ANNEXON INC
|
Healthcare | 0.00% | 0.45% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.00% | 0.45% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-75,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LPCN
LIPOCINE INC
|
Healthcare | 0.00% | 0.71% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-221,616 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.00% | 0.95% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-125,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CALL
REPLIMUNE GROUP...
|
|
CALL Option | 0.00% | 1.10% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-1,275,600 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.00% | 1.97% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-250,401 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.00% | 2.72% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-45 of 45 holdings